Skip to content

All Press Releases

PILA PHARMA AB, a Swedish biotech company, announces change to registration as public company and new Chairman of the Board elect

Malmö, Sweden, May 26, 2021 The Swedish Companies Registration Office (“Bolagsverket”) today, formally registered recent changes to the company as decided at the 2021 Annual General Assembly. The changes registered relates to  mandate to the Board of Directors to issue new shares, convertibles and/or warrants elect of Fredrik Buch to new Chairman of the Board of Directors change of the…

Read more

PILA PHARMA AB, a Swedish biotech company, announces adjustment to the management team to prepare for coming upscaling of the company.

Malmö, Sweden, May 21, 2021 “I am pleased to share the information that we have promoted Lars Bukhave Rasmussen, to become Chief Operating Officer (COO).  Further, I’m proud to announce the appointment of Elna Lembrér Åström, to new Chief Financial Officer (CFO)”, says CEO Dorte X. Gram.  Lars Bukhave Rasmussen joined PILA PHARMA in September 2020 as the company’s first CFO…

Read more

PILA PHARMA announces successful completion of Pre-IPO

Malmö, Sweden, 10 March 2021 PILA PHARMA AB, a Swedish biotech company, today, announces the successful completion of a recent new shares issue (Pre-IPO).  “I am very happy to share the information that we have successfully raised the 15 MSEK that we set out to do and previously communicated we would”, says CEO Dorte X. Gram.  Besides supplying the company…

Read more

Contact us

Subscription for press releases
Back To Top